Qing Yuan Li
Directeur Financier/CFO chez CytoPharm, Inc.
Profil
Qing Yuan Li is currently the President, CFO, Director & IR Contact at CytoPharm, Inc. He previously worked as a Director at Merit Biotech, Inc. Dr. Li holds a doctorate degree from Colorado State University and an undergraduate degree from National Taiwan University.
Postes actifs de Qing Yuan Li
| Sociétés | Poste | Début |
|---|---|---|
CytoPharm, Inc.
 CytoPharm, Inc. Pharmaceuticals: MajorHealth Technology CytoPharm, Inc. engages in the biopharmaceutical industry. The company specializes in protein drug development. It focuses on producing human natural cytokines such as interferon, interleukin and chemokine as modulators of human immune system. The products can be utilized in single or cocktail treatment model for chronic virus hepatitis, various oncology diseases, virus infection and autoimmune diseases. The company was founded on February 12, 2003 and is headquartered in Taipei, Taiwan. | Directeur Financier/CFO | 22/09/2011 |
Anciens postes connus de Qing Yuan Li
| Sociétés | Poste | Fin |
|---|---|---|
| MERIT BIOTECH INC | Directeur/Membre du Conseil | - |
Formation de Qing Yuan Li
| Colorado State University | Doctorate Degree |
| National Taiwan University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MERIT BIOTECH INC | Health Technology |
| Entreprise privées | 1 |
|---|---|
CytoPharm, Inc.
CytoPharm, Inc. Pharmaceuticals: MajorHealth Technology CytoPharm, Inc. engages in the biopharmaceutical industry. The company specializes in protein drug development. It focuses on producing human natural cytokines such as interferon, interleukin and chemokine as modulators of human immune system. The products can be utilized in single or cocktail treatment model for chronic virus hepatitis, various oncology diseases, virus infection and autoimmune diseases. The company was founded on February 12, 2003 and is headquartered in Taipei, Taiwan. | Health Technology |
